Maki Urushihara

3.4k total citations
81 papers, 2.5k citations indexed

About

Maki Urushihara is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Maki Urushihara has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 23 papers in Molecular Biology and 23 papers in Nephrology. Recurrent topics in Maki Urushihara's work include Renin-Angiotensin System Studies (39 papers), Hormonal Regulation and Hypertension (22 papers) and Renal Diseases and Glomerulopathies (16 papers). Maki Urushihara is often cited by papers focused on Renin-Angiotensin System Studies (39 papers), Hormonal Regulation and Hypertension (22 papers) and Renal Diseases and Glomerulopathies (16 papers). Maki Urushihara collaborates with scholars based in Japan, United States and Germany. Maki Urushihara's co-authors include Shoji Kagami, Hiroyuki Kobori, Yasuhiro Kuroda, Naro Ohashi, Shuji Kondo, Koji Yasutomo, Chinami Hashimura, Hiroshi Tsukamoto, Takahiko Horiuchi and Ryousuke Satou and has published in prestigious journals such as Circulation, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Maki Urushihara

79 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maki Urushihara Japan 29 1.0k 699 631 590 519 81 2.5k
Alison J. Cox Australia 35 1.1k 1.1× 961 1.4× 882 1.4× 1.2k 2.1× 180 0.3× 71 3.6k
Isao Ebihara Japan 34 525 0.5× 347 0.5× 1.4k 2.2× 961 1.6× 373 0.7× 90 3.3k
Noritaka Kawada Japan 21 641 0.6× 410 0.6× 643 1.0× 682 1.2× 129 0.2× 40 2.1k
Ashio Yoshimura Japan 23 528 0.5× 316 0.5× 1.3k 2.1× 730 1.2× 242 0.5× 75 2.7k
Juan Rodríguez‐Vita Spain 23 623 0.6× 238 0.3× 340 0.5× 1.4k 2.3× 556 1.1× 36 2.9k
Christiane Viedt Germany 19 367 0.4× 317 0.5× 227 0.4× 567 1.0× 600 1.2× 22 1.9k
Pamela W. Anderson United States 26 427 0.4× 1.1k 1.6× 327 0.5× 524 0.9× 252 0.5× 41 2.6k
Natalia López‐Andrés Spain 30 976 1.0× 471 0.7× 171 0.3× 911 1.5× 1.1k 2.1× 99 2.9k
U. Helmchen Germany 22 476 0.5× 175 0.3× 745 1.2× 357 0.6× 425 0.8× 65 2.2k
Hiroyuki Yamada Japan 23 542 0.5× 251 0.4× 170 0.3× 552 0.9× 497 1.0× 77 2.0k

Countries citing papers authored by Maki Urushihara

Since Specialization
Citations

This map shows the geographic impact of Maki Urushihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Urushihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Urushihara more than expected).

Fields of papers citing papers by Maki Urushihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maki Urushihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Urushihara. The network helps show where Maki Urushihara may publish in the future.

Co-authorship network of co-authors of Maki Urushihara

This figure shows the co-authorship network connecting the top 25 collaborators of Maki Urushihara. A scholar is included among the top collaborators of Maki Urushihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maki Urushihara. Maki Urushihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Urushihara, Maki, et al.. (2020). (Pro)renin receptor promotes crescent formation via the ERK1/2 and Wnt/β-catenin pathways in glomerulonephritis. American Journal of Physiology-Renal Physiology. 319(4). F571–F578. 6 indexed citations
3.
Nagai, Takashi, Yukiko Kinoshita, Maki Urushihara, et al.. (2019). Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation. CEN Case Reports. 8(4). 261–265. 7 indexed citations
4.
Ansary, Tuba M., Maki Urushihara, Yoshihide Fujisawa, et al.. (2018). Effects of the selective chymase inhibitor TEI‐F00806 on the intrarenal renin–angiotensin system in salt‐treated angiotensin I‐infused hypertensive mice. Experimental Physiology. 103(11). 1524–1531. 11 indexed citations
5.
Urushihara, Maki, et al.. (2016). (Pro)renin and (pro)renin receptor expression during kidney development in neonates. European Journal of Pediatrics. 176(2). 183–189. 14 indexed citations
6.
Urushihara, Maki & Shoji Kagami. (2016). Role of the intrarenal renin–angiotensin system in the progression of renal disease. Pediatric Nephrology. 32(9). 1471–1479. 55 indexed citations
8.
Urushihara, Maki, et al.. (2014). Urinary angiotensinogen level is increased in preterm neonates. Clinical and Experimental Nephrology. 19(2). 293–297. 12 indexed citations
9.
Ishizawa, Keisuke, Yuki Izawa‐Ishizawa, Noriko Yamano, et al.. (2014). Nitrosonifedipine Ameliorates the Progression of Type 2 Diabetic Nephropathy by Exerting Antioxidative Effects. PLoS ONE. 9(1). e86335–e86335. 10 indexed citations
10.
Suga, Kenichi, Yukiko Kinoshita, Maki Urushihara, et al.. (2013). A case of infantile systemic lupus erythematosus with severe lupus nephritis and EBV infection. CEN Case Reports. 2(2). 190–193. 2 indexed citations
11.
Rafiq, Kazi, Takahisa Noma, Yoshihide Fujisawa, et al.. (2012). Renal Sympathetic Denervation Suppresses De Novo Podocyte Injury and Albuminuria in Rats With Aortic Regurgitation. Circulation. 125(11). 1402–1413. 107 indexed citations
12.
Suga, Kenichi, et al.. (2012). Glomerular Expression of Hydrogen Peroxide-Inducible Clone-5 in Human and Rat Progressive Mesangial Proliferative Glomerulonephritis. Nephron Experimental Nephrology. 120(2). e59–e68. 5 indexed citations
14.
Alfaro-Ruíz, Luis, et al.. (2011). Variants and Haplotypes in Angiotensinogen Gene Are Associated With Plasmatic Angiotensinogen Level in Mexican Population. The American Journal of the Medical Sciences. 342(3). 205–211. 15 indexed citations
15.
Urushihara, Maki & Shoji Kagami. (2011). Urinary Angiotensinogen as a Biomarker of Nephropathy in Childhood. International Journal of Nephrology. 2011. 1–7. 5 indexed citations
16.
Kobori, Hiroyuki, Arnold Alper, Akemi Katsurada, et al.. (2008). Urinary Angiotensinogen as a Novel Biomarker of the Intrarenal Renin-Angiotensin System Status in Hypertensive Patients. Hypertension. 53(2). 344–350. 166 indexed citations
17.
Urushihara, Maki, et al.. (2007). . Japanese journal of pediatric nephrology. 20(1). 48–51.
18.
Kondo, Shuji, M. Shimizu, Maki Urushihara, et al.. (2006). Addition of the Antioxidant Probucol to Angiotensin II Type I Receptor Antagonist Arrests Progressive Mesangioproliferative Glomerulonephritis in the Rat. Journal of the American Society of Nephrology. 17(3). 783–794. 34 indexed citations
19.
Urushihara, Maki, Shoji Kagami, Koji Yasutomo, et al.. (2004). Sisters with a-mannosidosis and systemic lupus erythematosus. European Journal of Pediatrics. 163(4-5). 192–195. 26 indexed citations
20.
Kagami, Shoji, Maki Urushihara, Klemens Löster, et al.. (2000). Overexpression of α1β1 integrin directly affects rat mesangial cell behavior. Kidney International. 58(3). 1088–1097. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026